Tobacco-free Nicotine: No Smoke, No Fire for BAT?

British American is expanding into tobacco- and smoke-free nicotine products but we expect the new unit to remain a relatively small part of the company’s top line

Philip Gorham, CFA 6 April, 2011 | 9:16AM
Facebook Twitter LinkedIn

British American Tobacco (BATS) will develop tobacco-free nicotine products at its newly created Nicoventures unit in an attempt to retain revenue from smokers who wish to quit on health grounds. We regard the move as a hedge against declining rates of smoking in developed markets, and we expect the new unit to remain a very small piece of British American's top line for several years. Although we think British American is a solid business, we think the stock's recent rally has overshot the intrinsic value of the firm, and we recommend value investors look to Imperial Tobacco (IMT) for value in the tobacco industry.

British American's new business will negotiate with global regulators with a view to launching cigarette-replacement products. Regulators could prove to be a significant hurdle, in our opinion, because in recent years their efforts have been focused on the reduction or even abolition of the use of nicotine and tobacco. Smokeless tobacco is increasingly being used in the United States as an alternative to smoking, but such products are banned in the European Union (except Sweden), and we think the EU may provide the most lucrative market for British American's new venture. Reynolds American (RAI) acquired a smoking-cessation product manufacturer in 2009 in a similar hedge against declining rates of smoking. However, these products remain a tiny piece of Reynolds' business, and even smokeless is small. We estimate that revenue from smokeless tobacco will represent just 12% of Altria's total revenue by 2020. Similarly, we expect Nicoventures to remain insignificant for the foreseeable future.

Given that we do not expect any impact on the stock as a result of this venture, we think British American is slightly overvalued at 15 times forward earnings. We recommend investors look at Imperial Tobacco for value in the tobacco industry. The firm is the best placed of its competitors to exploit growth at both ends of the pricing scale in tobacco, but the stock is trading at just 11 times 2011 earnings and offers around 10% upside, in our opinion.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
British American Tobacco PLC2,969.00 GBX1.57Rating

About Author

Philip Gorham, CFA  Philip Gorham, CFA, is an associate director of equity research for Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures